Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Low-background versus no-background hydromorphone PCIA after gastrointestinal surgery
ChiCTR2100054317Phase 4Completed
- Sponsor
- Xijing Hospital
- Start
- Dec 2021
- Modality
- Orthosteric Ligands → Classical Binding Small Molecules → Small Molecules
- Countries
- 1
01
Overview
Phase 4, open-label trial of hydromorphone in postoperative pain (2 arms), sponsored by Xijing Hospital. Primary endpoint: Integrated area under an SpO2 saturation threshold of 95% per hour during the first 48 hours after surgery. Started Dec 2021; status: completed.
02
Drugs
hydromorphone
03
Conditions
postoperative pain
Beyond the preview
Go deeper on ChiCTR2100054317.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ChiCTR2100054317.